Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
2.100
+0.120 (6.06%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $31.29 million as of June 18, 2026. Its market cap has decreased by -46.98% in one year.
Market Cap
31.29M
Enterprise Value
10.10M
1-Year Change
-46.98%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $31.29M, a decrease of -75.00%. That is a compound annual growth rate of -46.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 31.29M | 53.37% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABVC BioPharma | 34.11M |
| Aligos Therapeutics | 32.67M |
| Daré Bioscience | 32.51M |
| Actinium Pharmaceuticals | 32.32M |
| Boundless Bio | 32.12M |
| Lisata Therapeutics | 32.05M |
| NanoViricides | 31.89M |
| Senti Biosciences Holdings | 29.02M |